You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Board of Directors of BONESUPPORT HOLDING AB has applied for the company's shares to be admitted to trading on Nasdaq Stockholm's main market. Nasdaq Stockholm has approved the company's application subject to customary conditions. The objective is to broaden the shareholder base through a neAlready a subscriber Login You…
Vaccibody has decided to change its financial reporting from NGAAP (Norwegian Generally Accepted Accounting Principles) and instead adopt IFRS (International Financial Reporting Standards) as its new accounting standard. Vaccibody has experienced a continued growing international interest in its Already a subscriber Login You have read all your free articles, to…
InDex Pharmaceuticals terminated a license agreement with Almirall S.A. involving the drug candidate Kappaproct® for the treatment of ulcerative colitis. The agreement had given Almirall licensed exclusive rights to Kappaproct® for the European market. Now InDex regains all worldwide development aAlready a subscriber Login You have read all your free…
Novo Nordisk has reached a resolution with the US federal government and the states about an investigation launched in February 2011 concerning sales and marketing practices for Victoza, a medicine to treat type 2 diabetes. The investigation was disclosed by Novo Nordisk for the first time in a cAlready a…
